Yoshida, M., Yokota, E., Sakuma, T., Yamatsuji, T., Takigawa, N., Ushijima, T., . . . Naomoto, Y. (2018). Development of an integrated CRISPRi targeting ΔNp63 for treatment of squamous cell carcinoma. Oncotarget.
Stile di citazione ChicagoYoshida, Masakazu, Etsuko Yokota, Tetsushi Sakuma, Tomoki Yamatsuji, Nagio Takigawa, Toshikazu Ushijima, Takashi Yamamoto, Takuya Fukazawa, e Yoshio Naomoto. "Development of an Integrated CRISPRi Targeting ΔNp63 for Treatment of Squamous Cell Carcinoma." Oncotarget 2018.
Citazione MLAYoshida, Masakazu, et al. "Development of an Integrated CRISPRi Targeting ΔNp63 for Treatment of Squamous Cell Carcinoma." Oncotarget 2018.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.